Overcoming resistance to fulvestrant (ICI182,780) by Downregulating the c-ABL Proto-Oncogene in breast cancer

Enhanced Resistance to Tamoxifen by the c-ABL Proto-oncogene in Breast Cancer

(2015) Huajun Zhao et al.   NEOPLASIA

New Strategies in Estrogen Receptor-Positive Breast Cancer

(2010) S. R. D. Johnston   CLINICAL CANCER RESEARCH

c-Abl regulates estrogen receptor α transcription activity through its stabilization by phosphorylation

(2010) X He et al.   ONCOGENE

Loss of Phosphatase and Tensin Homologue Deleted on Chromosome 10 Engages ErbB3 and Insulin-Like Growth Factor-I Receptor Signaling to Promote Antiestrogen Resistance in Breast Cancer

(2009) T. W. Miller et al.   CANCER RESEARCH

Cytoplasmic signalling by the c-Abl tyrosine kinase in normal and cancer cells

(2008) Audrey Sirvent et al.   BIOLOGY OF THE CELL

Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant

(2008) Thomas Frogne et al.   BREAST CANCER RESEARCH AND TREATMENT

Tyrosine Phosphorylation of the Nuclear Receptor Coactivator AIB1/SRC-3 Is Enhanced by Abl Kinase and Is Required for Its Activity in Cancer Cells

(2008) A. S. Oh et al.   MOLECULAR AND CELLULAR BIOLOGY